We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$41.2B
AUM Growth
+$785M
Cap. Flow
-$197M
Cap. Flow %
-0.48%
Top 10 Hldgs %
16.49%
Holding
2,297
New
154
Increased
708
Reduced
1,158
Closed
139

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$171M
2
RF icon
Regions Financial
RF
+$151M
3
BABA icon
Alibaba
BABA
+$109M
4
KO icon
Coca-Cola
KO
+$75.9M
5
AMCR icon
Amcor
AMCR
+$67.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 14.7%
3 Financials 10.86%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUI icon
376
Sun Communities
SUI
$15.8B
$18.3M 0.04%
142,880
+1,200
+0.8% +$149K
JAZZ icon
377
Jazz Pharmaceuticals
JAZZ
$16.1B
$18.2M 0.04%
127,377
+50,895
+67% +$6.84M
MCK icon
378
McKesson
MCK
$104B
$18M 0.04%
133,992
-2,392
-2% -$298K
INTU icon
379
Intuit
INTU
$91.1B
$18M 0.04%
68,829
+53,242
+342% +$13.5M
LEVI icon
380
Levi Strauss
LEVI
$9.49B
$17.9M 0.04%
857,684
-187,316
-18% -$4.12M
ATXS
381
DELISTED
Astria Therapeutics
ATXS
$17.7M 0.04%
364,900
PLAN
382
DELISTED
Anaplan, Inc.
PLAN
$17.7M 0.04%
350,000
+115,040
+49% +$4.76M
REAL icon
383
The RealReal
REAL
$1.41B
$17.6M 0.04%
+610,000
New +$17.6M
GILD icon
384
Gilead Sciences
GILD
$165B
$17.6M 0.04%
259,939
-7,263
-3% -$478K
UAL icon
385
United Airlines
UAL
$38.8B
$17.5M 0.04%
200,277
-60,895
-23% -$5.15M
SWX icon
386
Southwest Gas
SWX
$6.64B
$17.5M 0.04%
194,886
-3,060
-2% -$260K
DHI icon
387
D.R. Horton
DHI
$41.2B
$17.3M 0.04%
401,349
-539,814
-57% -$23.9M
WBA
388
DELISTED
Walgreens Boots Alliance
WBA
$17.2M 0.04%
314,736
-147,338
-32% -$7.83M
AVLR
389
DELISTED
Avalara, Inc.
AVLR
$17.2M 0.04%
237,835
+73,835
+45% +$4.77M
KBH icon
390
KB Home
KBH
$3.5B
$17.1M 0.04%
664,435
-79,466
-11% -$2.05M
WMGI
391
DELISTED
Wright Medical Group Inc
WMGI
$17.1M 0.04%
572,295
-25,879
-4% -$789K
CL icon
392
Colgate-Palmolive
CL
$74.8B
$17M 0.04%
237,002
+205,652
+656% +$14.6M
QTS
393
DELISTED
QTS REALTY TRUST, INC.
QTS
$16.9M 0.04%
365,900
+61,400
+20% +$2.8M
PAYC icon
394
Paycom
PAYC
$7.88B
$16.8M 0.04%
74,315
+70,914
+2,085% +$14.6M
CRL icon
395
Charles River Laboratories
CRL
$11.3B
$16.8M 0.04%
118,629
+10,208
+9% +$1.38M
MSM icon
396
MSC Industrial Direct
MSM
$6.76B
$16.8M 0.04%
226,539
-3,198
-1% -$247K
IQV icon
397
IQVIA
IQV
$40.7B
$16.8M 0.04%
104,201
+51,995
+100% +$7.29M
KEM
398
DELISTED
KEMET Corporation
KEM
$16.7M 0.04%
890,351
+186,175
+26% +$3.26M
DAVA icon
399
Endava
DAVA
$165M
$16.7M 0.04%
415,148
+150,000
+57% +$5.07M
VCEL icon
400
Vericel Corp
VCEL
$2.38B
$16.7M 0.04%
884,400
+683,803
+341% +$11.7M

Similar funds

Federated Hermes's Q2 2019 Portfolio in Review

As of Q2 2019, Federated Hermes held 2,297 positions worth $41.2B, up 1.9% from $40.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2019 filing shows 154 new, 708 increased, 1,158 reduced and 139 closed positions. Its largest new stake was Amcor: 1,210,171 shares worth $69.5M. The largest sale was American Electric Power, an estimated $183M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q2 2019 buy was Amcor: 1,210,171 shares worth $69.5M.
  • Federated Hermes added most to Pfizer in Q2 2019, an estimated $171M increase.
  • Federated Hermes's biggest Q2 2019 reduction was American Electric Power, cutting an estimated $183M.
  • Federated Hermes fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $41.2B portfolio in Q2 2019.
  • Federated Hermes opened 154 new positions and closed 139 in Q2 2019.
  • Federated Hermes's portfolio value rose 1.9% quarter-over-quarter to $41.2B.

Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.